Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Tomlins

Showing results (31-40 of 231) with videos related to

Pageof 24
Sort By:
European Journal of Endocrinology|May 12, 2016
Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutationsKazutaka Nanba, Kei Omata, Scott A Tomlins, et al.
Prostate Cancer and Prostatic Diseases|March 10, 2019
SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomyFarzana A Faisal, Harsimar B Kaur, Jeffrey J Tosoian, et al.
Cancer Research|April 19, 2005
Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva)Prakash Chinnaiyan, Shyhmin Huang, Geetha Vallabhaneni, et al.
JCO Precision Oncology|September 26, 2025
Immune and Genomic Heterogeneity of MET-Altered Non-Small Cell Lung CancerManlu Liu, Rachel L Minne, Saahil Javeri, et al.
The Prostate|March 15, 2012
Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer modelsBushra Ateeq, Adaikkalam Vellaichamy, Scott A Tomlins, et al.
European Urology|May 5, 2009
ETS gene fusions in prostate cancer: from discovery to daily clinical practiceScott A Tomlins, Anders Bjartell, Arul M Chinnaiyan, et al.
Science (New York, N.Y.)|November 26, 2009
Induced chromosomal proximity and gene fusions in prostate cancerRam-Shankar Mani, Scott A Tomlins, Kaitlin Callahan, et al.
Cancer|August 18, 2015
Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsySelin Merdan, Scott A Tomlins, Christine L Barnett, et al.
Hormones & Cancer|January 30, 2015
Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer ProgressionJake Higgins, Michele Brogley, Nallasivam Palanisamy, et al.
Proceedings of Spie--The International Society for Optical Engineering|May 23, 2017
Prostate cancer characterization by optical contrast enhanced photoacousticsGuan Xu, Ming Qin, Ananya Mukundan, et al.
Pageof 24

Showing results (31-40 of 231) with videos related to

Sort By:
Pageof 24
European Journal of Endocrinology|May 12, 2016
Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutationsKazutaka Nanba, Kei Omata, Scott A Tomlins, et al.
Prostate Cancer and Prostatic Diseases|March 10, 2019
SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomyFarzana A Faisal, Harsimar B Kaur, Jeffrey J Tosoian, et al.
Cancer Research|April 19, 2005
Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva)Prakash Chinnaiyan, Shyhmin Huang, Geetha Vallabhaneni, et al.
JCO Precision Oncology|September 26, 2025
Immune and Genomic Heterogeneity of MET-Altered Non-Small Cell Lung CancerManlu Liu, Rachel L Minne, Saahil Javeri, et al.
The Prostate|March 15, 2012
Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer modelsBushra Ateeq, Adaikkalam Vellaichamy, Scott A Tomlins, et al.
European Urology|May 5, 2009
ETS gene fusions in prostate cancer: from discovery to daily clinical practiceScott A Tomlins, Anders Bjartell, Arul M Chinnaiyan, et al.
Science (New York, N.Y.)|November 26, 2009
Induced chromosomal proximity and gene fusions in prostate cancerRam-Shankar Mani, Scott A Tomlins, Kaitlin Callahan, et al.
Cancer|August 18, 2015
Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsySelin Merdan, Scott A Tomlins, Christine L Barnett, et al.
Hormones & Cancer|January 30, 2015
Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer ProgressionJake Higgins, Michele Brogley, Nallasivam Palanisamy, et al.
Proceedings of Spie--The International Society for Optical Engineering|May 23, 2017
Prostate cancer characterization by optical contrast enhanced photoacousticsGuan Xu, Ming Qin, Ananya Mukundan, et al.
Pageof 24